Identification of a crucial residue required for Staphylococcus aureus LukAB cytotoxicity and receptor recognition

Infection and Immunity

Volumn 82, Issue 3, 2014, Pages 1268-1276

  DuMont, Ashley L ^a,d   Yoong, Pauline ^a   Liu, Xiang ^a   Day, Christopher J ^b   Chumbler, Nicole M ^c   James, David B A ^a   Alonzo III, Francis ^a   Bode, Nadine J ^a   Borden Lacy, D ^c   Jennings, Michael P ^b   Torres, Victor J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRIFFITH UNIVERSITY   (Australia)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ANTIGENS, CD11B; BACTERIAL PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; EXOTOXINS; GLUTAMIC ACID; HL-60 CELLS; HUMANS; LEUKOCIDINS; PROTEIN BINDING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84894266542     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01444-13     Document Type: Article

References (34)

1. Rigby KM, DeLeo FR. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin. Immunopathol. 34:237-259. http://dx.doi.org/10.1007/s00281-011-0295-3.
2. Vandenesch F, Lina G, Henry T. 2012. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front. Cell. Infect. Microbiol. 2:12. http://dx.doi.org/10.3389/fcimb.2012.00012.
3. Alonzo F, III, Torres VJ. 2013. Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. PLoS Pathog. 9:e1003143. http://dx.doi.org/10.1371/journal.ppat.1003143.
4. Yoong P, Torres VJ. 2013. The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr. Opin. Microbiol. 16:63-69. http://dx.doi.org/10.1016/j.mib.2013.01.012.
5. Panton PN, Valentine FCO. 1932. Staphylococcal toxin. Lancet i:506-508.
6. Smith ML, Price SA. 1938. Staphylococcus γ haemolysin. J. Pathol. Bacteriol. 47:379-393. http://dx.doi.org/10.1002/path.1700470303.
7. Pedelacq JD, Maveyraud L, Prevost G, Baba-Moussa L, Gonzalez A, Courcelle E, Shepard W, Monteil H, Samama JP, Mourey L. 1999. The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Structure 7:277-287. http://dx.doi.org/10.1016 /S0969-2126(99)80038-0.
8. Guillet V, Roblin P, Werner S, Coraiola M, Menestrina G, Monteil H, Prevost G, Mourey L. 2004. Crystal structure of leucotoxinScomponent:newinsight into the Staphylococcal beta-barrel pore-forming toxins. J. Biol. Chem. 279:41028-41037. http://dx.doi.org/10.1074/jbc.M406904200.
9. Olson R, Nariya H, Yokota K, Kamio Y, Gouaux E. 1999. Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat. Struct. Biol. 6:134-140. http://dx.doi.org/10.1038/5821.
10. Yamashita K, Kawai Y, Tanaka Y, Hirano N, Kaneko J, Tomita N, Ohta M, Kamio Y, Yao M, Tanaka I. 2011. Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore for-mation mechanism by two components. Proc. Natl. Acad. Sci. U. S. A. 108:17314-17319. http://dx.doi.org/10.1073/pnas.1110402108.
11. Woodin AM. 1960. Purification of the two components of leucocidin from Staphylococcus aureus. Biochem. J. 75:158-165.
12. Colin DA, Mazurier I, Sire S, Finck-Barbancon V. 1994. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect. Immun. 62:3184-3188.
13. Alonzo F, III, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D, Torres VJ. 2013. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493:51-55. http: //dx.doi.org/10.1038/nature11724.
14. Reyes-Robles T, Alonzo F, III, Kozhaya L, Lacy DB, Unutmaz D, Torres VJ. 2013. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14:453-459. http://dx.doi.org/10.1016/j.chom .2013.09.005.
15. Yokota K, Kamio Y. 2000. Tyrosine72 residue at the bottom of rim domain in LukF crucial for the sequential binding of the staphylococcal gamma-hemolysin to human erythrocytes. Biosci. Biotechnol. Biochem. 64:2744-2747. http://dx.doi.org/10.1271/bbb.64.2744.
16. DuMont AL, Torres VJ. 2014. Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. Trends Microbiol. 22:21-27. http://dx.doi.org/10.1016/j.tim.2013.10.004.
17. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, Aerts PC, Kemmink J, de Haas CJ, van Kessel KP, Vandenesch F, Lina G, van Strijp JA. 2013. The staphylococcal toxin Panton-Valentine leukocidin targets human c5a receptors. Cell Host Microbe 13:584-594. http://dx.doi .org/10.1016/j.chom.2013.04.006.
18. DuMont AL, Yoong P, Day CJ, Alonzo F, III, McDonald WH, Jennings MP, Torres VJ. 2013. Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc. Natl. Acad. Sci. U. S. A. 110:10794-10799. http://dx.doi.org/10.1073/pnas .1305121110.
19. Jayasinghe L, Bayley H. 2005. The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis. Protein Sci. 14:2550-2561. http://dx.doi.org/10 .1110/ps.051648505.
20. Dumont AL, Nygaard TK, Watkins RL, Smith A, Kozhaya L, Kreiswirth BN, Shopsin B, Unutmaz D, Voyich JM, Torres VJ. 2011. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol. Microbiol. 79:814-825. http://dx.doi.org/10.1111/j.1365-2958.2010.07490.x.
21. Ventura CL, Malachowa N, Hammer CH, Nardone GA, Robinson MA, Kobayashi SD, DeLeo FR. 2010. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS One 5:e11634. http://dx.doi.org/10.1371/journal.pone.0011634.
22. Malachowa N, Kobayashi SD, Braughton KR, Whitney AR, Parnell MJ, Gardner DJ, Deleo FR. 2012. Staphylococcus aureus leukotoxin GH promotes inflammation. J. Infect. Dis. 206:1185-1193. http://dx.doi.org/10 .1093/infdis/jis495.
23. DuMont AL, Yoong P, Surewaard BG, Benson MA, Nijland R, van Strijp JA, Torres VJ. 2013. Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect. Immun. 81:1830-1841. http://dx.doi.org/10.1128/IAI.00095-13.
24. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. 2008. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J. Bacteriol. 190:300-310. http://dx.doi.org/10 .1128/JB.01000-07.
25. Duthie ES, Lorenz LL. 1952. Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6:95-107. http://dx.doi.org/10.1099 /00221287-6-1-2-95.
26. Boles BR, Thoendel M, Roth AJ, Horswill AR. 2010. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One 5:e10146. http://dx.doi.org/10.1371/journal .pone.0010146.
27. Torres VJ, Attia AS, Mason WJ, Hood MI, Corbin BD, Beasley FC, Anderson KL, Stauff DL, McDonald WH, Zimmerman LJ, Friedman DB, Heinrichs DE, Dunman PM, Skaar EP. 2010. Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect. Immun. 78:1618-1628. http://dx.doi .org/10.1128/IAI.01423-09.
28. Alonzo F, III, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ.2012. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol. Microbiol. 83:423-435. http://dx.doi.org/10.1111/j.1365-2958.2011 .07942.x.
29. Yoong P, Pier GB. 2010. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc. Natl. Acad. Sci. U. S. A. 107:2241-2246. http://dx.doi.org/10.1073/pnas .0910344107.
30. Menzies BE, Kernodle DS. 1996. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect. Immun. 64:1839-1841.
31. Aman MJ, Karauzum H, Bowden MG, Nguyen TL. 2010. Structural model of the pre-pore ring-like structure of Panton-Valentine leukocidin: providing dimensionality to biophysical and mutational data. J. Biomol. Struct. Dyn. 28:1-12. http://dx.doi.org/10.1080/073911010010524952.
32. Miles G, Movileanu L, Bayley H. 2002. Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore. Protein Sci. 11:894-902. http://dx.doi.org/10.1110/ps.4360102.
33. Roblin P, Guillet V, Joubert O, Keller D, Erard M, Maveyraud L, Prevost G, Mourey L. 2008. A covalent S-F heterodimer of leucotoxin reveals molecular plasticity of beta-barrel pore-forming toxins. Proteins 71:485-496. http://dx.doi.org/10.1002/prot.21900.
34. Miles G, Jayasinghe L, Bayley H. 2006. Assembly of the bi-component leukocidin pore examined by truncation mutagenesis. J. Biol. Chem. 281: 2205-2214. http://dx.doi.org/10.1074/jbc.M510842200.